Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort-Reference-Cited by-同舟云学术

Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort

Published:2023-03-15 Issue:1 Volume:69 Page:45-55
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Ungaro Ryan C.^ORCID,Naegeli April N.,Choong Casey Kar-Chan,Shan Mingyang,Zheng Xianming Steve,Hunter Gibble Theresa,Oneacre Kathy,Colombel Jean-Frederic

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-023-07906-4.pdf

Reference29 articles.

1. Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389:1741–1755.

2. Hamdeh S, Aziz M, Altayar O, Olyaee M, Murad MH, Hanauer SB. Early vs late use of anti-TNFa therapy in adult patients with Crohn disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2020;26:1808–1818.

3. Berg DR, Colombel JF, Ungaro R. The role of early biologic therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1896–1905.

4. Targownik LE, Kaplan GG, Witt J et al. Longitudinal trends in the direct costs and health care utilization ascribable to inflammatory bowel disease in the biologic era: results from a Canadian population-based analysis. Am J Gastroenterol. 2020;115:128–137.

5. Ungaro RC, Aggarwal S, Topaloglu O, Lee WJ, Clark R, Colombel JF. Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease. Aliment Pharmacol Ther. 2020;51:831–842.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023;Intestinal Research;2024-07-31

2. White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States–Removing Barriers and Embracing Opportunities;Clinical Gastroenterology and Hepatology;2024-05

3. The Earlier You Find, the Better You Treat: Red Flags for Early Diagnosis of Inflammatory Bowel Disease;Diagnostics;2023-10-12